Health
State of Health Brazil results show China's Sinovac vaccine is just 50.4 percent effective against COVID-19
Just Earth News | @justearthnews | 14 Jan 2021, 09:56 pm Print
China COVID-19 Vaccine Brazilian clinical trials have unveiled that a COVID-19 vaccine developed by China's Sinovac has been found to be 50.4% effective, media reports said.
It shows the vaccine is significantly less effective than previous data suggested - barely over the 50% needed for regulatory approval, reports BBC.
The vaccine is one of the two which the Brazilian government has lined up.
Brazil is one of the worst-hit COVID-19 nations in the world.
Sinovac, a Beijing-based biopharmaceutical company, is behind CoronaVac, an inactivated vaccine. It works by using killed viral particles to expose the body's immune system to the virus without risking a serious disease response, reports BBC.
More Health
- Heatwaves could be harming children’s mental health, study warns
- New study finds sleep is the biggest predictor of academic success in teens
- Viagra may do more than treat erectile dysfunction—Scientists find potential cancer benefit
- New study challenges high-protein diet trend with a surprising finding
- Can this walking plan melt your belly fat? Study gives the answer
-1786284396.jpg "Image of the day: August 9, 2026")
-1785937004.jpg "Image of the day: August 5, 2026")
